Article Details

AbbVie to buy Cerevel Therapeutics in $8.7 billion all-cash deal - Morningstar

Retrieved on: 2023-12-06 22:03:38

Tags for this article:

Click the tags to see associated articles and topics

AbbVie to buy Cerevel Therapeutics in $8.7 billion all-cash deal - Morningstar. View article details on hiswai:

Excerpt

... neuroscience pipeline adds medications that may transform standards of ... "Our existing neuroscience portfolio and our combined pipeline with ...

Article found on: www.morningstar.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo